1 / 49

Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights

Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights. Data on Nebulized Levofloxacin and Guidance on Psychosocial Support. Nebulized Levofloxacin For Chronic P aeruginosa infection. Results. Results (cont). Depression and Anxiety in Patients With CF.

nolcha
Download Presentation

Research Advances in Cystic Fibrosis Expert Interpretations and Clinical Insights

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Research Advances in Cystic FibrosisExpert Interpretations and Clinical Insights

  2. Data on Nebulized Levofloxacin and Guidance on Psychosocial Support

  3. Nebulized Levofloxacin For Chronic P aeruginosa infection

  4. Results

  5. Results (cont)

  6. Depression and Anxiety in Patients With CF

  7. Best Practice Guidelines: Psychosocial Support

  8. Best Practice Guidelines: Psychosocial Support (cont)

  9. Key Transition Points

  10. An Update on Ivacaftor and the Evolving Role of MRI

  11. Background

  12. KONDUCT Study

  13. KONDUCT Study (cont)

  14. Additional Findings

  15. Additional Findings (cont)

  16. Investigators’ Conclusion

  17. MRI Detection of Lung Ventilation Defects in CF

  18. Additional Results

  19. MRI Assessment of Response to Therapy

  20. Additional Findings

  21. Take-home Points

  22. MRI Evaluation of Pulmonary Blood Flow

  23. Take-home Point

  24. Recommendations For Exercise and For CFTR Modulator Therapy

  25. The Importance of Exercise in CF

  26. Results

  27. Best Practices: CFTR Modulator Therapy

  28. Best Practices: CFTR Modulator Therapy (cont)

  29. Best Practices: CFTR Modulator Therapy (cont)

  30. The Ronan et al Study

  31. Does Ivacaftor Improve Lung Function By Altering Airway Microbiology?

  32. Effect of Ivacaftor on Mucociliary Clearance

  33. KONNECTION Study

  34. Results

  35. Take-home Points

  36. New Findings on Inhaled Antibiotic Therapies

  37. Once-daily Inhaled Liposomal Amikacin

  38. Study Design

  39. Highlights of Efficacy Results

  40. Highlights of Efficacy Results (cont)

  41. Highlights of Safety Results

  42. Take-home Point

  43. Incorporating a Third Inhaled Antipseudomonal Antibiotic Class

  44. Highlights of Results

  45. Highlights of Results (cont)

  46. Abbreviations

  47. References

  48. References (cont)

  49. References (cont)

More Related